SPHBIO
Updated 363 days ago
Shanghai Pharma Biotherapeutics USA Inc. (SPHBio) is a wholly-owned subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH), one of the largest pharmaceutical companies in China. SPH is a vertically-integrated and diversified pharmaceutical group...
SPH is a vertically-integrated and diversified pharmaceutical group. The company has dual listings on the stock exchanges in Shanghai (601607) and Hong Kong (02067), respectively. The company provides leading healthcare services in: Research & Development; Manufacturing; Distribution; and, Retail. SPH has developed and delivered healthcare solutions and effective medicines to patients in China for the past century. SPH is committed to continuously bringing innovative medicines to patients that alleviate or cure diseases.
Also known as: SPH